Sign in
Enrolling by invitationNo phase

Swallowable camera capsule to examine the stomach before weight loss surgery

Tests a magnet-guided camera capsule in people preparing for weight loss surgery.

Key facts

Who runs it
Jerry Dang
Where
Cleveland, United StatesSee the site
Trial code
Registry title
Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery
Status
Enrolling by invitation
People taking part
30 people, planned
Started
1 Aug 2025
Expected to end
30 Jan 2027
Type of study
Interventional
Treatments tested
  • Magnetically Controlled Capsule Endoscopy (MCCE)
Record updated
14 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with severe obesity who are preparing for a first weight loss surgery. They will swallow a magnetically controlled camera capsule to examine the upper digestive tract.

Age
18 years or older
Sex
All sexes can join
Disease stage
Diagnosed with morbid obesity, BMI greater than 38 kg/m² and up to 65 kg/m², waist circumference up to 77 inches, having a first (primary) weight loss surgery according to current international guidelines
Earlier treatment
Previous abdominal surgeries with a suspected risk of bowel adhesions are an exclusion

Main reasons for not taking part

  • Permanent pacemaker or other surgically placed metal device that can interfere with the magnetic field
  • Trouble swallowing, or risk of the capsule getting stuck (for example blocked stomach outlet, narrowed intestine, inflammatory bowel disease)
  • Upper digestive symptoms that need a regular endoscopy (EGD)
  • Currently taking part in another clinical study
  • Does not speak English

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age ≥ 18 years old
  • Diagnosed with morbid obesity
  • Undergoing primary bariatric surgery by current international guidelines
  • BMI greater than 38 kg/m² and less than or equal to 65 kg/m²
  • Waist circumference less than or equal to 77 inches

Who cannot take part

  • Patients with dysphagia and those who are at risk of capsule retention (gastric outlet obstruction, intestinal stenosis, inflammatory bowel disease, previous abdominal surgeries with suspicious of adhesive bowel disease)
  • Patients with permanent pacemakers and other surgically placed metallic devices which function can interfere with the magnetic field
  • Patients with reported upper gastrointestinal symptoms who would require a conventional EGD
  • Patients currently participating in other clinical studies
  • Patients who do not speak English

Where in United States

  • Cleveland Clinic FoundationCleveland, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The goal of this clinical trial is to test if a swallowable camera capsule can safely examine the upper digestive tract in people preparing for weight loss surgery. The camera capsule (called NaviCam® Xpress™ Stomach System) is controlled by magnets from outside the body and doesn't require sedation, unlike traditional endoscopy. The main questions it aims to answer are:

Read full original descriptionShow less

Can the camera capsule be safely used in people with a body mass index (BMI) greater than 38? Can doctors successfully control and move the camera capsule to see the necessary areas of the stomach and esophagus? Researchers will evaluate 30 participants who are preparing for weight loss surgery.

Participants will:

Swallow the camera capsule with water after not eating or drinking since midnight Have their upper digestive tract examined while the doctor controls the capsule from outside their body Complete a brief satisfaction survey about their experience Be followed up with a phone call 2-3 weeks after the procedure

This study could help determine if the camera capsule is a good alternative to traditional endoscopy for people preparing for weight loss surgery, potentially avoiding the need for sedation.

The group in the trial

  • Magnetically Controlled Capsule Endoscopy (MCCE) ArmTreatment being tested

    Participants will undergo preoperative upper gastrointestinal tract evaluation using the NaviCam® Xpress™ Stomach System, a magnetically controlled capsule endoscopy device. After fasting overnight, participants will swallow the capsule with 500ml of water. The capsule will initially be tethered and will capture images as it descends the esophagus. Once positioned appropriately, the tether will be released via 15ml air injection, and the surgeon will control the capsule's movement in the stomach using an external magnetic control system. All participants will be followed for 14-21 days post-procedure.

    Treatment: Magnetically Controlled Capsule Endoscopy (MCCE)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery: A Feasibility Prospective Trial
Plain-language title
Swallowable camera capsule to examine the stomach before weight loss surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
14 May 2026